Buy & Sell TJX Companies Inc (TJX) – TJX Companies Inc Price Today
Aura AI Summary
Key Stats
- $166.16BMarket Cap
- Consumer CyclicalSector
- -9.75%3M Drawdown
- $173.42BEnterprise Value
- 1.28%Dividend Yield
- 18% Buy | 82% SellTrading Activity
- 93 daysTypical Hold Time
TJX Companies Inc (TJX) is currently valued at a market capitalization of $166.16B, with an enterprise value of $173.42B. Over the past 52 weeks, TJX Companies Inc has traded between a low of $121.35 and a high of $165, highlighting its annual price range. Over the past three months, TJX Companies Inc has recorded a drawdown of -9.75%, reflecting recent price volatility. TJX Companies Inc offers a dividend yield of 1.28%, with the most recent dividend of $0.43 paid on 12 Feb 26. On average, investors hold TJX Companies Inc for approximately 93 days, indicating typical investor behavior on the platform.
About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Most Recent News
Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost
Quantum Cyber has secured an exclusive license for BP United's autonomous drone technology, including a sky defense platform capable of over 25 km range and fully autonomous operations. This move positions Quantum Cyber to capitalize on the Trump adm...
Corbus Pharmaceuticals to present at RBC and Jefferies healthcare conferences in May and June 2026
Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focused on oncology and obesity therapies, announced CEO Yuval Cohen will present corporate updates and meet investors at two major healthcare conferences in New York: the RBC Capital ...
Digital fraud attempts in Canada exceed global average; median loss per victim is CAD 1,301 in 2025
In 2025, Canada experienced a higher rate of suspected digital fraud attempts (4.4%) compared to the global average (3.8%), with 13% of Canadians reporting financial losses averaging CAD 1,301. Credit card fraud was the most common cause, followed by...
